Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency

RecruitingOBSERVATIONAL

Enrollment

1,600

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

Heart FailureLevosimendanMilrinoneEfficacySafety

Trial Locations (1)

RECRUITING

First Affiliated Hospital of Shandong First Medical University ( Qianfoshan Hospital of Shandong Province ), Jinan

All Listed Sponsors

collaborator

Qianfoshan Hospital

OTHER

lead

Yi Han

OTHER